Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeroen van Eijk

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
AJR. American Journal of Roentgenology|May 25, 2011
Neuralgic amyotrophyJeroen van Eijk, Nens van Alfen
The Cochrane Database of Systematic Reviews|January 1, 2014
Immunotherapy for idiopathic lumbosacral plexopathyJeroen van Eijk, Yee Cheun Chan, James W Russell
Expert Review of Anti-Infective Therapy|February 28, 2018
Non-traumatic neurological injury and hepatitis E infectionPaolo Ripellino, Benjamin Norton, Jeroen van Eijk, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 17, 2017
Inflammatory natalizumab-associated PML: baseline characteristics, lesion evolution and relation with PML-IRISMike P Wattjes, Martijn T Wijburg, Jeroen van Eijk, et al.
Neurology|August 4, 2017
Five cases of malignant melanoma during fingolimod treatment in Dutch patients with MSJoep Killestein, Cyra E Leurs, Erwin L J Hoogervorst, et al.
International Journal of Cardiology. Heart & Vasculature|September 2, 2024
Clinical determinants and biomarkers associated with cardiac fibrosis after heart transplantation as assessed by magnetic resonance: Size mattersAnne Vorlat, Jeroen van Eijk, Sjoerd Wiersma, et al.
Resuscitation|July 14, 2026
Ventilation parameters during Advanced Life Support in cardiac arrest (CAvent): A multicentre observational cohort studyJohan Mälberg, Lotte Doeleman, Jeroen van Eijk, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 25, 2025
Low natalizumab trough concentrations are associated with reduced seroconversion of the John Cunningham virus in natalizumab-treated patients with multiple sclerosisLiza M Y Gelissen, Alyssa A Toorop, Pien M Schipper, et al.
European Journal of Neurology|July 7, 2026
Individual Variability of CD19+ B-Cell Repopulation in People With Multiple Sclerosis Treated With Extended Interval Dosing of OcrelizumabLaura Hogenboom, Lisa G Schoof, Liza M Y Gelissen, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
AJR. American Journal of Roentgenology|May 25, 2011
Neuralgic amyotrophyJeroen van Eijk, Nens van Alfen
The Cochrane Database of Systematic Reviews|January 1, 2014
Immunotherapy for idiopathic lumbosacral plexopathyJeroen van Eijk, Yee Cheun Chan, James W Russell
Expert Review of Anti-Infective Therapy|February 28, 2018
Non-traumatic neurological injury and hepatitis E infectionPaolo Ripellino, Benjamin Norton, Jeroen van Eijk, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 17, 2017
Inflammatory natalizumab-associated PML: baseline characteristics, lesion evolution and relation with PML-IRISMike P Wattjes, Martijn T Wijburg, Jeroen van Eijk, et al.
Neurology|August 4, 2017
Five cases of malignant melanoma during fingolimod treatment in Dutch patients with MSJoep Killestein, Cyra E Leurs, Erwin L J Hoogervorst, et al.
International Journal of Cardiology. Heart & Vasculature|September 2, 2024
Clinical determinants and biomarkers associated with cardiac fibrosis after heart transplantation as assessed by magnetic resonance: Size mattersAnne Vorlat, Jeroen van Eijk, Sjoerd Wiersma, et al.
Resuscitation|July 14, 2026
Ventilation parameters during Advanced Life Support in cardiac arrest (CAvent): A multicentre observational cohort studyJohan Mälberg, Lotte Doeleman, Jeroen van Eijk, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 25, 2025
Low natalizumab trough concentrations are associated with reduced seroconversion of the John Cunningham virus in natalizumab-treated patients with multiple sclerosisLiza M Y Gelissen, Alyssa A Toorop, Pien M Schipper, et al.
European Journal of Neurology|July 7, 2026
Individual Variability of CD19+ B-Cell Repopulation in People With Multiple Sclerosis Treated With Extended Interval Dosing of OcrelizumabLaura Hogenboom, Lisa G Schoof, Liza M Y Gelissen, et al.
Pageof 1